Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Eli Lilly and Company    LLY

ELI LILLY AND COMPANY

(LLY)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Eli Lilly and : , Incyte Say FDA Grants EUA for Baricitinib

11/19/2020 | 05:59pm EST

By Stephen Nakrosis

Eli Lilly and Co. and Incyte on Thursday said the U.S. Food and Drug Administration issued an emergency use authorization for Baricitinib to treat hospitalized patients with Covid-19.

The EUA "enables use of baricitinib in combination with remdesivir in hospitalized patients needing oxygen," the companies said.

The EUA is based on data from the Adaptive COVID-19 Treatment Trial conducted by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, the companies said. Among the findings, the companies said were that "patients treated with baricitinib in combination with remdesivir had a significant reduction in median time to recovery from 8 to 7 days compared to remdesivir," and "patients treated with baricitinib in combination with remdesivir were more likely to have a better clinical status at Day 15 compared to patients treated with remdesivir."

Baricitinib is an oral JAK inhibitor that was discovered by Incyte and licensed to Lilly, the companies said.

--Write to Stephen Nakrosis at stephen.nakrosis@wsj.com

(END) Dow Jones Newswires

11-19-20 1759ET

Stocks mentioned in the article
ChangeLast1st jan.
ELI LILLY AND COMPANY 1.87% 206.14 Delayed Quote.22.09%
INCYTE CORPORATION 4.25% 97.89 Delayed Quote.7.96%
All news about ELI LILLY AND COMPANY
01/22ELI LILLY AND : BofA Securities Adjusts Eli Lilly and Company PT to $225 From $1..
MT
01/22ELI LILLY AND COMPANY : - Lilly's neutralizing antibody bamlanivimab prevented C..
AQ
01/21ELI LILLY AND : Says Trial of Monoclonal Antibody Among Nursing Home, Staff Resi..
MT
01/21ELI LILLY AND : Lilly's neutralizing antibody bamlanivimab (LY-CoV555) prevented..
AQ
01/21ELI LILLY AND : Says Late-Stage Trial Shows Antibody Bamlanivimab Effective in P..
MT
01/21Lilly Antibody Drug Prevents Covid-19 in Nursing Homes, Study Finds
DJ
01/21ELI LILLY AND : Lilly's neutralizing antibody bamlanivimab (LY-CoV555) prevented..
PR
01/20ELI LILLY AND : (LLY) Insider Makes Significant Share Sale
MT
01/20ELI LILLY AND : Thinking about trading options or stock in General Motors, Eli L..
PR
01/20FULCRUM THERAPEUTICS : Announces Promotion of Christopher Moxham Ph.D. to Chief ..
AQ
More news
Financials (USD)
Sales 2020 24 415 M - -
Net income 2020 5 821 M - -
Net Debt 2020 11 301 M - -
P/E ratio 2020 32,3x
Yield 2020 1,44%
Capitalization 187 B 187 B -
EV / Sales 2020 8,12x
EV / Sales 2021 7,12x
Nbr of Employees 33 625
Free-Float 99,8%
Chart ELI LILLY AND COMPANY
Duration : Period :
Eli Lilly and Company Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ELI LILLY AND COMPANY
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 21
Average target price 191,87 $
Last Close Price 206,14 $
Spread / Highest target 10,1%
Spread / Average Target -6,92%
Spread / Lowest Target -41,8%
EPS Revisions
Managers and Directors
NameTitle
David A. Ricks Chairman, President & Chief Executive Officer
Joshua L. Smiley Chief Financial Officer & Senior Vice President
Timothy J. Garnett Chief Medical Officer & VP-Global Medical
Aarti S. Shah Chief Information & Digital Officer, Senior VP
Daniel M. Skovronsky Chief Scientific Officer & Senior Vice President
Sector and Competitors
1st jan.Capitalization (M$)
ELI LILLY AND COMPANY22.09%186 883
JOHNSON & JOHNSON3.92%430 552
ROCHE HOLDING AG3.06%308 615
NOVARTIS AG2.73%220 726
MERCK & CO., INC.-1.00%204 882
PFIZER INC.-0.71%203 159